Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Kinex Pharmaceuticals, Zenith Technology deal

Kinex granted Zenith marketing rights to cancer candidates Oraxol and Oratecan in Australia and New Zealand. Oraxol is

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE